Aidsmap

Last updated
Aidsmap
Formation1987
FounderPeter Scott
PurposeIndependent, accurate & accessible information about HIV
HeadquartersUnited Kingdom
Executive Director
Matthew Hodson
Website www.aidsmap.com
Formerly called
National Aids Manual

Aidsmap, also known as NAM aidsmap, was a website which published independent, accurate and accessible information and news about HIV and AIDS. [1] [2] [3] [4] The aidsmap website was run by a charity based in the United Kingdom, NAM. [1] The site closed in July 2024 due to challenges securing funding. [5]

Contents

"NAM" originally stood for "national AIDS manual" and referred to a 1987 compendium of all information about HIV published for non-scientists in England. [6] [7] [2] [8] Since aidsmap became an international organisation, [3] NAM was no longer used as an acronym and there was no longer any particular "aids manual" being maintained. [9] [10] [2]

NAM aidsmap's vision was of a world where HIV is no longer a threat to health or happiness.

Timeline of work

NAM was founded in 1987 [2] by Peter Scott, [6] [11] who was then working for the London Lesbian and Gay Switchboard. He was seeking to address the public's demand for a source of information about HIV. [12]

Subsequent Directors were Will Anderson (to 1996), [13] Colin Nee (1996–2001), [13] [14] Caspar Thomson (2001–2016) [15] [13] and Matthew Hodson (2016–2024). [15] [16] [17]

In 1992 the organisation began publishing the newsletter now called the HIV Treatment Update, [18] which was designed to give patients the information they need to help direct their choices for HIV treatment. [12] [19] [20] [21]

In 1998 aidsmap.com was launched as an online resource [2] [22] [23] for all printed materials. It was a partnership project involving NAM and The British HIV Association, [23] [22] [24] and later the International HIV/AIDS Alliance. The original site editors were Edward King [25] and Keith Alcorn. [26] From 2018 to 2024, the editor was Roger Pebody. [27]

In 2006 aidsmap.com was awarded first prize in the Patient Information Website category of the 2006 British Medical Association’s (BMA) Medical Books Competition. [28]

In 2019, NAM aidsmap launched its new aidsmap website after a major redevelopment project. [29]

In December 2019, aidsmapLIVE, an HIV information series broadcast on NAM's social media channels, won both the Innovation and Media award at the nOscars, hosted by Naz Project London. [30] [31]

In 2024, NAM, the organisation publishing aidsmap, faced a funding crisis and was forced to close. [32] In response, Winnie Byanyima, the Executive Director of the United Nations joint AIDS programme UNAIDS paid tribute to the organisation's work. “You have been a trusted source and resource for people living with HIV and everyone in the global HIV response. You leave an exceptional legacy.” Byanyima said. [33]

The International AIDS Society also stated that the closure of the service would leave a significant void: “NAM has consistently delivered unparalleled commentary and coverage of critical HIV-related news. It is now more imperative than ever for all stakeholders in the HIV response to intensify our efforts to fill this significant void.” they said. [34]

Related Research Articles

<span class="mw-page-title-main">Joint United Nations Programme on HIV/AIDS</span> United Nations organization

The Joint United Nations Programme on HIV and AIDS is the main advocate for accelerated, comprehensive and coordinated global action on the HIV/AIDS pandemic.

<span class="mw-page-title-main">Zidovudine</span> Antiretroviral medication

Zidovudine (ZDV), also known as azidothymidine (AZT), was the first antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use in combination with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein.

HIV-positive people, seropositive people or people who live with HIV are people infected with the human immunodeficiency virus (HIV), a retrovirus which if untreated may progress to acquired immunodeficiency syndrome (AIDS).

<span class="mw-page-title-main">HIV/AIDS in India</span>

HIV/AIDS in India is an epidemic. The National AIDS Control Organisation (NACO) estimated that 3.14 million people lived with HIV/AIDS in India in 2023. Despite being home to the world's third-largest population of persons with HIV/AIDS, the AIDS prevalence rate in India is lower than that of many other countries. In 2016, India's AIDS prevalence rate stood at approximately 0.30%—the 80th highest in the world. Treatment of HIV/AIDS is via a combination of antiretroviral drugs and education programs to help people avoid infection.

<span class="mw-page-title-main">Pre-exposure prophylaxis for HIV prevention</span> HIV prevention strategy using preventative medication for HIV-negative individuals

Pre-exposure prophylaxis for HIV prevention, commonly known as PrEP, is a form of medication used to prevent HIV infection, the cause of HIV/AIDS.

HIV/AIDS was first diagnosed in 1981. As of year-end 2018, 160,493 people have been diagnosed with HIV in the United Kingdom and an estimated 7,500 people are living undiagnosed with HIV. New diagnoses are highest in gay/bisexual men, with an estimated 51% of new diagnosis reporting male same-sex sexual activity as the probable route of infection. Between 2009 and 2018 there was a 32% reduction in new HIV diagnosis, attributed by Public Health England (PHE) to better surveillance and education. PHE has described an "outbreak" in Glasgow amongst people who inject drugs, and has campaigns targeting men who have sex with men in London and other major cities. London was the first city in the world to reach the World Health Organization target for HIV, set at 90% of those with HIV diagnosed, 90% of those diagnosed on HAART and 90% of those on HAART undetectable. The UK as a whole later achieved the same target. Under the Equality Act 2010, it is illegal to discriminate against someone based on their HIV status in the UK.

Ibalizumab, sold under the brand name Trogarzo, is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to the CD4 receptor on the surface of a CD4 cell. Post-attachment inhibitors are a subclass of HIV drugs called entry inhibitors.

Long-term nonprogressors (LTNPs), are individuals infected with HIV, who maintain a CD4 count greater than 500 without antiretroviral therapy with a detectable viral load. Many of these patients have been HIV positive for 30 years without progressing to the point of needing to take medication in order not to develop AIDS. They have been the subject of a great deal of research, since an understanding of their ability to control HIV infection may lead to the development of immune therapies or a therapeutic vaccine. The classification "Long-term non-progressor" is not permanent, because some patients in this category have gone on to develop AIDS.

<span class="mw-page-title-main">Elvitegravir</span> Chemical compound

Elvitegravir (EVG) is an integrase inhibitor used to treat HIV infection. It was developed by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008. The drug gained approval by the U.S. Food and Drug Administration on August 27, 2012, for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild. On September 24, 2014, the FDA approved Elvitegravir as a single pill formulation under the trade name Vitekta. On November 5, 2015, the FDA approved the drug for use in patients affected with HIV-1 as a part of a second fixed dose combination pill known as Genvoya.

<span class="mw-page-title-main">Health in Vietnam</span>

Health in Vietnam encompasses general and specific concerns to the region, its history, and various socioeconomic status, such as dealing with malnutrition, effects of Agent Orange as well as psychological issues from the Vietnam War, tropical diseases, and other issues such as underdeveloped healthcare systems or inadequate ratio of healthcare or social workers to patients.

<span class="mw-page-title-main">Avert (HIV and AIDS organisation)</span> British charitable organization

Avert is an international charity that uses digital communications to increase health literacy on HIV and sexual health, among those most affected in areas of greatest need, in order to reduce new infections and improve health and well-being.

The National AIDS Trust is a United Kingdom charity with the purpose to stand alongside and defend the rights of everyone living with, affected by or at risk of HIV. Its expertise, research and advocacy secure lasting change to the lives of people living with and at risk of HIV. The charity's key strategic goals are:

The Naz Foundation (India) Trust is a non-governmental organisation (NGO) in that country that works on HIV/AIDS and sexual health. It is based in the Indian capital of New Delhi.

<span class="mw-page-title-main">HIV/AIDS research</span> Field of immunology research

HIV/AIDS research includes all medical research that attempts to prevent, treat, or cure HIV/AIDS, as well as fundamental research about the nature of HIV as an infectious agent and AIDS as the disease caused by HIV.

Dame Anne Mandall Johnson DBE FMedSci is a British epidemiologist, known for her work in public health, especially the areas of HIV, sexually transmitted infections and infectious diseases.

Viral load monitoring for HIV is the regular measurement of the viral load of individual HIV-positive people as part of their personal plan for treatment of HIV/AIDS. A count of the viral load is routine before the start of HIV treatment.

<span class="mw-page-title-main">Bictegravir</span> Chemical compound

Bictegravir is a second-generation integrase inhibitor (INSTI) class that was structurally derived from an earlier compound dolutegravir by scientists at Gilead Sciences. In vitro and clinical results were presented by Gilead in the summer of 2016. In 2016, bictegravir was in a Phase 3 trial as part of a single tablet regimen in combination with tenofovir alafenamide (TAF) and emtricitabine (FTC) for the treatment of HIV-1 infection.

<span class="mw-page-title-main">Edinburgh City Hospital</span> Hospital in Edinburgh, Scotland

The Edinburgh City Hospital was a hospital in Colinton, Edinburgh, opened in 1903 for the treatment of infectious diseases. As the pattern of infectious disease changed, the need for in-patients facilities to treat them diminished. While still remaining the regional centre for infectious disease, in the latter half of the 20th century the hospital facilities diversified with specialist units established for respiratory disease, ear, nose and throat surgery, maxillo-facial surgery, care of the elderly and latterly HIV/AIDS. The hospital closed in 1999 and was redeveloped as residential housing, known as Greenbank Village.

<span class="mw-page-title-main">Cabotegravir/rilpivirine</span> Co-packaged antiretroviral medication

Cabotegravir/rilpivirine, sold under the brand name Cabenuva, is a co-packaged antiretroviral medication for the treatment of HIV/AIDS. It contains cabotegravir and rilpivirine in a package with two separate injection vials.

<span class="mw-page-title-main">Lenacapavir</span> Antiretroviral medication

Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. It is taken by mouth or by subcutaneous injection.

References

  1. 1 2 "NAM PUBLICATIONS - Charity 1011220". register-of-charities.charitycommission.gov.uk. Retrieved 2022-09-21.
  2. 1 2 3 4 5 Morris, Martin (2017). "Aidsmap.com: A Comprehensive HIV/AIDS Information Resource". Journal of Consumer Health on the Internet. 21 (4): 402–409. doi:10.1080/15398285.2017.1377545. S2CID   80617999 . Retrieved 27 April 2022.
  3. 1 2 Silverman, Taylor; Asante, Nicole; van den Berg, Jacob J (2018-10-16). "Quality of HIV Websites With Information About Pre-Exposure Prophylaxis or Treatment as Prevention for Men Who Have Sex With Men: Systematic Evaluation". JMIR Public Health and Surveillance. 4 (4): e11384. doi: 10.2196/11384 . ISSN   2369-2960. PMC   6231722 . PMID   30327291.
  4. ↑ Shelling, Gene M. (2006). AIDS Policies and Programs. Nova Publishers. ISBN   978-1-60021-217-8.
  5. ↑ "Thank you and farewell". July 2024.
  6. 1 2 "Archives of NAM (National AIDS Manual)". Wellcome Collection. Retrieved 2022-09-21.
  7. ↑ Anthony, Pinching (1993). "Book reviews". Journal of the Royal College of Physicians of London. 27 (1): 88–89. PMC   5396607 .
  8. ↑ Mann, Cass (1998) [16 October]. "Aids charity 'should not have lost its funding'". The Kingston Informer. p. 4.
  9. ↑ "HIV & AIDS Information :: Who we are - Our name". aidsmap.com. 2011. Retrieved 24 June 2011.
  10. ↑ "Sex Talk". www.sextalk.radio. Retrieved 2022-09-21.
  11. ↑ "Medicine and the Media". British Medical Journal. 310 (6979): 607. 1995-03-04. ISSN   0959-8138. PMC   2548979 .
  12. 1 2 "HIV & AIDS Information :: Thirty years on". aidsmap.com. 5 June 2011. Retrieved 24 June 2011.
  13. 1 2 3 "NAM PUBLICATIONS filing history - Find and update company information - GOV.UK". find-and-update.company-information.service.gov.uk. Retrieved 2022-10-14.
  14. ↑ Weatherburn, P., et al. "What do you need? 2001-02: findings from a national survey of people living with HIV." (2002).
  15. 1 2 "Meet Matthew Hodson, the New Executive Director of NAM". POZ. 2016-07-25. Retrieved 2022-10-14.
  16. ↑ "This year's 30 charity leaders on social media: be bold to succeed". The Guardian. 17 November 2017. Retrieved 27 April 2022.
  17. ↑ "Matthew Hodson stands down as aidsmap's Executive Director after 8 years". aidsmap. 6 June 2024. Retrieved 15 July 2024.
  18. ↑ Berridge, Virginia (2002). "AIDS and the rise of the patient? Activist organisation and HIV/AIDS in the UK in the 1980s and 1990s". Medizin, Gesellschaft, und Geschichte: Jahrbuch des Instituts für Geschichte der Medizin der Robert Bosch Stiftung. 21: 109–123. ISSN   0939-351X. PMID   13677353.
  19. ↑ "AIDS Treatment Update : 15% discount to NAM Manual subscribers / NAM". Wellcome Collection. Retrieved 2022-09-21.
  20. ↑ Lau, R. K. (1996). "Genitourinary medicine and the Internet. No 2". Sexually Transmitted Infections. 72 (5): 380–381. doi:10.1136/sti.72.5.380. PMC   1195710 . PMID   8976859.
  21. ↑ "NOTES". British Medical Journal. 304 (6828): 718.2. 1992-03-14. doi:10.1136/bmj.304.6828.718-e. ISSN   0959-8138. PMC   1881552 .
  22. 1 2 "aidsmap.com : the direct route to information on aids / NAM, British HIV Association". Wellcome Collection. Retrieved 2022-09-23.
  23. 1 2 "Great Britain launches new Aids web site". The Nation. Vol. 23. Thailand. Reuters. 1998 [24 Jun 1998]. p. 8.
  24. ↑ Shafer, R. W.; Deresinski, S. C. (2000). "Human Immunodeficiency Virus on the Web: A Guided Tour". Clinical Infectious Diseases. 31 (2): 568–577. doi:10.1086/313952. PMC   2573401 . PMID   10987723.
  25. ↑ "Edward King Archive". Bishopsgate Institute. Retrieved 2022-09-23.
  26. ↑ "An introduction to aidsmap.com : HIV treatment information on the world wide web / Keith Alcorn". Wellcome Collection. Retrieved 2022-09-23.
  27. ↑ "Roger Pebody Managing Editor". aidsmap.com. Retrieved 5 Sep 2024.
  28. ↑ "Electronic patient information awards announced". Digital Health. 2006-09-13. Retrieved 2022-09-23.
  29. ↑ "Welcome to the new aidsmap". aidsmap.com. 19 July 2019. Retrieved 2022-09-23.
  30. ↑ Naz Project London [@nazprojectlondon] (18 December 2019). "@aidsmap have won the INNOVATION AWARD! CONGRATS!!" – via Instagram.
  31. ↑ Naz Project London [@nazprojectlondon] (18 December 2019). "@aidsmap have won the MEDIA AWARD! CONGRATS!!" – via Instagram..
  32. ↑ Adewale, Dami. "HIV support charity closes after 37 years". Third Sector. Retrieved 15 July 2024.
  33. ↑ Watson, Graeme (2 July 2024). "Charity NAM aidsmap set to close after 37 years". Out in Perth. Retrieved 15 July 2024.
  34. ↑ Watson, Graeme (2 July 2024). "Charity NAM aidsmap set to close after 37 years". Out in Perth. Retrieved 15 July 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.